Literature DB >> 23449046

Characterizing the HIV epidemic in the prairie provinces.

Marissa L Becker1, Ken Kasper, Carla Pindera, Mary Cheang, Debbie Rodger, Stephen Sanche, Stuart Skinner, M John Gill.   

Abstract

BACKGROUND: The numbers and demographics of HIV-positive patients in care between 2003 and 2007 in the prairie provinces were examined.
METHODS: Estimates of HIV-positive patients presenting to care between 2003 and 2007 were obtained from four clinic registries in Manitoba, Saskatchewan and southern Alberta. Detailed data were collected from clinical records of new patients in 2007.
RESULTS: By the end of December 2007, 2263 HIV-positive persons were in care in Manitoba, Saskatchewan and southern Alberta. Males and females accounted for 1674 (74.0%) and 589 of the cases, respectively. Overall, there was a 12% increase per year in new HIV cases to care between 2003 and 2007 (P=0.026), with the rate of increase for males being 60% higher than for females over this time period (P=0.002). In 2007, there were 222 new HIV cases to care (37.4% female). Heterosexual contact was the most common HIV risk, but diversity was seen across sites with frequent injection drug use and men who have sex with men risk in Saskatchewan and southern Alberta, respectively. The Aboriginal population remains heavily over-represented, with approximately 36.0% of new cases being Aboriginal. Late presentation was common across all care sites, with 35.1% of cases presenting with CD4 counts of less than 200 cells/mm(3). DISCUSSION: Heterosexual risk is the most common risk reported for HIV acquisition, but injection drug use risk remains significant in Saskatchewan. Aboriginals are over-represented at all sites, and in Saskatchewan accounted for the majority of new cases seen. In contrast to national trends, numbers of new and late diagnoses are increasing in the praire provinces, and this has significant treatment implications and potential public health consequences. Further efforts need to be made to facilitate earlier testing and linkage to care.
BACKGROUND: The numbers and demographics of HIV-positive patients in care between 2003 and 2007 in the prairie provinces were examined.
METHODS: Estimates of HIV-positive patients presenting to care between 2003 and 2007 were obtained from four clinic registries in Manitoba, Saskatchewan and southern Alberta. Detailed data were collected from clinical records of new patients in 2007.
RESULTS: By the end of December 2007, 2263 HIV-positive persons were in care in Manitoba, Saskatchewan and southern Alberta. Males and females accounted for 1674 (74.0%) and 589 of the cases, respectively. Overall, there was a 12% increase per year in new HIV cases to care between 2003 and 2007 (P=0.026), with the rate of increase for males being 60% higher than for females over this time period (P=0.002). In 2007, there were 222 new HIV cases to care (37.4% female). Heterosexual contact was the most common HIV risk, but diversity was seen across sites with frequent injection drug use and men who have sex with men risk in Saskatchewan and southern Alberta, respectively. The Aboriginal population remains heavily over-represented, with approximately 36.0% of new cases being Aboriginal. Late presentation was common across all care sites, with 35.1% of cases presenting with CD4 counts of less than 200 cells/mm3. DISCUSSION: Heterosexual risk is the most common risk reported for HIV acquisition, but injection drug use risk remains significant in Saskatchewan. Aboriginals are over-represented at all sites, and in Saskatchewan accounted for the majority of new cases seen. In contrast to national trends, numbers of new and late diagnoses are increasing in the praire provinces, and this has significant treatment implications and potential public health consequences. Further efforts need to be made to facilitate earlier testing and linkage to care.

Entities:  

Keywords:  Aboriginal; Care; Epidemiology; HIV; Prairie provinces

Year:  2012        PMID: 23449046      PMCID: PMC3374470          DOI: 10.1155/2012/408561

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  14 in total

Review 1.  Late diagnosis of HIV infection: major consequences and missed opportunities.

Authors:  Martin Fisher
Journal:  Curr Opin Infect Dis       Date:  2008-02       Impact factor: 4.915

2.  Should the CD4 threshold for starting ART be raised?

Authors:  Robin Wood; Stephen D Lawn
Journal:  Lancet       Date:  2009-04-08       Impact factor: 79.321

3.  Time to testing and accessing care among a population of newly diagnosed patients with HIV with a high proportion of Canadian Aboriginals, 1998-2003.

Authors:  Sabrina S Plitt; Dana Mihalicz; Ameeta E Singh; Gayatri Jayaraman; Stan Houston; Bonita E Lee
Journal:  AIDS Patient Care STDS       Date:  2009-02       Impact factor: 5.078

4.  Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, January 28, 2000 by the Panel on Clinical Practices for Treatment of HIV Infection.

Authors: 
Journal:  HIV Clin Trials       Date:  2000 Jul-Aug

5.  Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users.

Authors:  Evan Wood; Thomas Kerr; Anita Palepu; Ruth Zhang; Steffanie A Strathdee; Mark W Tyndall; Julio S G Montaner; Robert S Hogg
Journal:  J Infect       Date:  2005-09-19       Impact factor: 6.072

6.  Late presentation for human immunodeficiency virus care in the United States and Canada.

Authors:  Keri N Althoff; Stephen J Gange; Marina B Klein; John T Brooks; Robert S Hogg; Ronald J Bosch; Michael A Horberg; Michael S Saag; Mari M Kitahata; Amy C Justice; Kelly A Gebo; Joseph J Eron; Sean B Rourke; M John Gill; Benigno Rodriguez; Timothy R Sterling; Liviana M Calzavara; Steven G Deeks; Jeffrey N Martin; Anita R Rachlis; Sonia Napravnik; Lisa P Jacobson; Gregory D Kirk; Ann C Collier; Constance A Benson; Michael J Silverberg; Margot Kushel; James J Goedert; Rosemary G McKaig; Stephen E Van Rompaey; Jinbing Zhang; Richard D Moore
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

7.  Estimation of HIV incidence in the United States.

Authors:  H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

8.  Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Authors:  Scott M Hammer; Joseph J Eron; Peter Reiss; Robert T Schooley; Melanie A Thompson; Sharon Walmsley; Pedro Cahn; Margaret A Fischl; Jose M Gatell; Martin S Hirsch; Donna M Jacobsen; Julio S G Montaner; Douglas D Richman; Patrick G Yeni; Paul A Volberding
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

9.  Epidemiology of HIV in the United States and Canada: current status and ongoing challenges.

Authors:  H Irene Hall; Jennifer Geduld; David Boulos; Philip Rhodes; Qian An; Timothy D Mastro; Robert S Janssen; Chris P Archibald
Journal:  J Acquir Immune Defic Syndr       Date:  2009-05-01       Impact factor: 3.731

Review 10.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

Authors:  Jonathan A C Sterne; Margaret May; Dominique Costagliola; Frank de Wolf; Andrew N Phillips; Ross Harris; Michele Jönsson Funk; Ronald B Geskus; John Gill; François Dabis; Jose M Miró; Amy C Justice; Bruno Ledergerber; Gerd Fätkenheuer; Robert S Hogg; Antonella D'Arminio Monforte; Michael Saag; Colette Smith; Schlomo Staszewski; Matthias Egger; Stephen R Cole
Journal:  Lancet       Date:  2009-04-08       Impact factor: 79.321

View more
  6 in total

1.  Letter to the editor.

Authors:  Karan Sharma; Aditya Sharma; Kim Nichol; James Karlowsky; Marissa Becker; Ken Kasper; Yoav Keynan
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-03       Impact factor: 2.471

Review 2.  The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions.

Authors:  Katherine R Schafer; Helmut Albrecht; Rebecca Dillingham; Robert S Hogg; Denise Jaworsky; Ken Kasper; Mona Loutfy; Lauren J MacKenzie; Kathleen A McManus; Kris Ann K Oursler; Scott D Rhodes; Hasina Samji; Stuart Skinner; Christina J Sun; Sharon Weissman; Michael E Ohl
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

3.  Marked disparity in the epidemiology of tuberculosis among Aboriginal peoples on the Canadian prairies: the challenges and opportunities.

Authors:  Richard Long; Vernon Hoeppner; Pamela Orr; Martha Ainslie; Malcolm King; Sylvia Abonyi; Maria Mayan; Dennis Kunimoto; Deanne Langlois-Klassen; Courtney Heffernan; Angela Lau; Dick Menzies
Journal:  Can Respir J       Date:  2013-05-28       Impact factor: 2.409

Review 4.  mHealth Interventions to Promote Anti-Retroviral Adherence in HIV: Narrative Review.

Authors:  Stephen B Lee; Joanne Valerius
Journal:  JMIR Mhealth Uhealth       Date:  2020-08-28       Impact factor: 4.773

5.  A pilot behavioural and biological surveillance survey for HIV and other bloodborne infections among Aboriginal people in Regina, Saskatchewan.

Authors:  J Tarasuk; S Ogunnaike-Cooke; C Archibald; M Poitras; M Hennink; K Lloyd; R Faye; Z Abbas; C Bourassa; R Masching; R Bennett; R MacLean; L Malloch; J Kim
Journal:  Can Commun Dis Rep       Date:  2014-11-20

6.  Cohort profile: the LHIV-Manitoba clinical cohort of people living with HIV in Manitoba, Canada.

Authors:  Leigh M McClarty; Eve Cheuk; Laurie Ireland; Claire Kendall; Christine Bibeau; Carla Loeppky; Ken Kasper; Yoav Keynan; James Blanchard; Marissa Becker
Journal:  BMJ Open       Date:  2020-05-27       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.